Evidence map›Paper›PMID 32894859›Full record

ArticleUrologia internationalis2020

The Effect of the Presence of Lower Urinary System Symptoms on the Prognosis of COVID-19: Preliminary Results of a Prospective Study.

Ibrahim Karabulut, Ahmet Emre Cinislioglu, Nazan Cinislioglu, Fatih Kursat Yilmazel, Mustafa Utlu, Handan Alay, Erkan Cem Celik, Senol Adanur

Erratum issuedOpen access · bronzeAbstract read
In one paragraph

Article in Urologia internationalis, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 23 citations in OpenAlex.

  1. Longitudinal Evaluation of Lower Urinary Tract Symptoms up to Six Months after COVID-19 Infection in a Jordanian Cohort.Acta informatica medica : AIM : journal of the Society for Medical Informatics of Bosnia & Herzegovina : casopis Drustva za medicinsku informatiku BiH · 2025
    Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. SARS-CoV-2 Effects on the Male Genitourinary System.American journal of clinical and experimental urology · 2022
    Review
  7. COVID-19: systemic pathology and its implications for therapy.International journal of biological sciences · 2022
    Review
  8. Article
  9. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Ibrahim KarabulutDepartment of Urology, Health Sciences University Regional Training and Research Hospital, Erzurum, Turkey.
Ahmet Emre CinisliogluDepartment of Urology, Health Sciences University Regional Training and Research Hospital, Erzurum, Turkey, emrecinisli@hotmail.com.
Nazan CinisliogluDepartment of Infectious Diseases and Clinical Microbiology, Ataturk University Medical Faculty, Erzurum, Turkey.
Fatih Kursat YilmazelDepartment of Urology, Health Sciences University Regional Training and Research Hospital, Erzurum, Turkey.
Mustafa UtluDepartment of Internal Medicine, Health Sciences University Regional Training and Research Hospital, Erzurum, Turkey.
Handan AlayDepartment of Infectious Diseases and Clinical Microbiology, Ataturk University Medical Faculty, Erzurum, Turkey.
Erkan Cem CelikDepartment of Anesthesiology and Reanimation, Ataturk University Medical Faculty, Erzurum, Turkey.
Senol AdanurDepartment of Urology, Ataturk University Medical Faculty, Erzurum, Turkey.
Atatürk University · TRErzurum Regional Training and Research Hospital · TRSağlık Bilimleri Üniversitesi · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo investigate the effectiveness of benign prostatic hyperplasia (BPH)-related lower urinary tract symptoms (LUTS), which occur as a natural result of aging and androgen exposure, in predicting disease prognosis in male patients diagnosed with COVID-19.

methodsThe study was planned prospectively. The study included 63 male patients over 40 years of age diagnosed with COVID-19. The patients were diagnosed with COVID-19 based on the results of reverse transcription polymerase chain reaction tests of oropharyngeal and nasopharyngeal swabs obtained as per the World Health Organization guidelines. The presence of LUTS was assessed by the International Prostate Symptom Score (I-PSS), a subjective assessment, and the I-PSS was filled for the patients included in the study. The patients were divided into three groups based on their scores in the I-PSS survey: group 1: mild (0-7), group 2: moderate (8-19), and group 3: severe (20-35). The data of all three groups were statistically analyzed.

resultsIn the assessment performed between the groups, it was identified that for patients in group 3, the length of hospital stay was longer, intensive care requirement was more frequent, and their mortality rates were numerically higher. In the evaluation made regarding the time to intensive care admittance, this was identified to be the shortest in group 3.

conclusionAs a result of our study, we think that in patients with COVID-19, BPH-related LUTS can guide clinicians in predicting prognosis.

Indexed as

BetacoronavirusQuality of LifeAdultComorbidityCoronavirus InfectionsCOVID-19HumansLower Urinary Tract SymptomsMaleMiddle AgedPandemicsPneumonia, ViralPrognosisProspective StudiesProstatic HyperplasiaSARS-CoV-2Benign prostatic hyperplasiaCOVID-19International prostate symptom scoreLower urinary tract symptoms

Identifiers

PMID32894859
PMCPMC7573898
OpenAlexW3083317864

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.